Anthurium: A wholly-owned subsidiary obtains a registration certificate for concentrated solution of zoledronic acid for injection.

Announcement: One of our subsidiaries has obtained the registration certificate for concentrated solution of zoledronic acid for injection. The concentrated solution of zoledronic acid for injection is a national medical insurance category B product. The concentrated solution of zoledronic acid for injection approved by the company is declared for registration as a chemical drug class 4, and is considered to have passed consistency evaluation.